
Overview
Status
Active
Registry date
2021-02-12
Share capital
5,000.00 PLN
Activity description
Cigmed provides contract manufacturing of dietary supplements, covering the process from product concept to finished product. It specializes in capsules with modified-release micropellets, including mineral, vitamin and herbal supplements such as products with potassium, magnesium and iron.
Registered address
ul. Jatkowa 12, 18-400 Łomża, Poland
Website
Email
Electronic delivery address
AE:PL-15387-90834-CDIHA-27
Financials
Revenue history (in k)
Filing timeliness
5 of 5 financial statements were filed late (the longest delay 92 days for 2021).
- 202506/08/2026
- 202402/08/2025
- 202331/08/2024
- 202214/10/2023
- 202115/10/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Offer
- Potassium supplements
- Potassium and magnesium supplements
- Iron supplements
- Zinc supplements
- Vitamin supplements
- Contract manufacturing of supplements
Website technology
- Online shop
- WooCommerce
- Website
- WordPress
- Elementor
Authorized Representatives
Paweł Gorczyca – President of the Management Board
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Krzysztof Jerzy Calage 59 | 25 | $675.31 | 50% |
Paweł Gorczycaage 56 | 25 | $675.31 | 50% |
Beneficial owners
No beneficial owners recorded for the company Cigmed.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 12, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $10,898$10,898 | Polska Fundacja Ośrodków Wspomagania Rozwoju Gospodarczego Oic Poland z Siedzibą w Lublinie |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Prosuplement Groupsp. z o.o. | $34,819,545.29 | prosuplement.com | ||
| Global Pharma CmS.A. | $24,132,016.98 | globalpharma.pl | ||
| INV Poland sp. z o.o.sp. k. | $5,980,381.22 | invpoland.com | ||
| Supplelabsp. z o.o. + limited partnership | $5,146,355.45 | supplelab.pl | ||
| Bioticomsp. z o.o. | $2,901,963.26 | bioticom.pl | ||
| Nutri Partnersp. z o.o. | $1,480,720.01 | nutri-partner.com | ||
| Suplement.Iosp. z o.o. | $1,149,843.38 | suplement.io | ||
| IOCsp. z o.o. | $878,940.46 | producentsuplementow.pl | ||
| Fotam Groupsp. z o.o. | $122,168.40 | fotamgroup.pl | ||
| Fuelup Factorysp. z o.o. | $107,897.20 | fuelupfactory.com |
FAQ
The main business activity of Cigmed focuses on manufacture of other food products not elsewhere classified.
The company was registered in the Polish National Court Register (KRS) on February 12, 2021.
The headquarters is located at: ul. Jatkowa 12, 18-400 Łomża.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
Last updated: 2026-08-06